Egan James 4
4 · Sucampo Pharmaceuticals, Inc. · Filed May 4, 2011
Insider Transaction Report
Form 4
Egan James
Chief Operating Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2011-05-02+156,250→ 156,250 totalExercise: $4.41Exp: 2021-05-02→ Class A common stock (156,250 underlying)
Footnotes (1)
- [F1]Performance Conditions for vesting: 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $8/sh = 62,500; 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $12/sh = 62,500; and 20% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $16/sh = 31,250.